Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers

Understanding the mechanisms driving PI3K isoform dependency in prostate cancer can help the design of future clinical trials. Here, the authors show that gain-of-function mutations in PIK3CA or PIK3CB can confer PI3K p110 isoform dependency and that the direct inhibition of AKT may be superior to P...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ninghui Mao, Zeda Zhang, Young Sun Lee, Danielle Choi, Aura Agudelo Rivera, Dan Li, Cindy Lee, Samuel Haywood, Xiaoping Chen, Qing Chang, Guotai Xu, Hsuan-An Chen, Elisa de Stanchina, Charles Sawyers, Neal Rosen, Andrew C. Hsieh, Yu Chen, Brett S. Carver
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/907e2e85e15748fa85c06a824495c169
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:907e2e85e15748fa85c06a824495c169
record_format dspace
spelling oai:doaj.org-article:907e2e85e15748fa85c06a824495c1692021-12-02T17:08:26ZDefining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers10.1038/s41467-021-25341-92041-1723https://doaj.org/article/907e2e85e15748fa85c06a824495c1692021-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25341-9https://doaj.org/toc/2041-1723Understanding the mechanisms driving PI3K isoform dependency in prostate cancer can help the design of future clinical trials. Here, the authors show that gain-of-function mutations in PIK3CA or PIK3CB can confer PI3K p110 isoform dependency and that the direct inhibition of AKT may be superior to PI3K inhibition in PTEN-deficient prostate cancers.Ninghui MaoZeda ZhangYoung Sun LeeDanielle ChoiAura Agudelo RiveraDan LiCindy LeeSamuel HaywoodXiaoping ChenQing ChangGuotai XuHsuan-An ChenElisa de StanchinaCharles SawyersNeal RosenAndrew C. HsiehYu ChenBrett S. CarverNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Ninghui Mao
Zeda Zhang
Young Sun Lee
Danielle Choi
Aura Agudelo Rivera
Dan Li
Cindy Lee
Samuel Haywood
Xiaoping Chen
Qing Chang
Guotai Xu
Hsuan-An Chen
Elisa de Stanchina
Charles Sawyers
Neal Rosen
Andrew C. Hsieh
Yu Chen
Brett S. Carver
Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
description Understanding the mechanisms driving PI3K isoform dependency in prostate cancer can help the design of future clinical trials. Here, the authors show that gain-of-function mutations in PIK3CA or PIK3CB can confer PI3K p110 isoform dependency and that the direct inhibition of AKT may be superior to PI3K inhibition in PTEN-deficient prostate cancers.
format article
author Ninghui Mao
Zeda Zhang
Young Sun Lee
Danielle Choi
Aura Agudelo Rivera
Dan Li
Cindy Lee
Samuel Haywood
Xiaoping Chen
Qing Chang
Guotai Xu
Hsuan-An Chen
Elisa de Stanchina
Charles Sawyers
Neal Rosen
Andrew C. Hsieh
Yu Chen
Brett S. Carver
author_facet Ninghui Mao
Zeda Zhang
Young Sun Lee
Danielle Choi
Aura Agudelo Rivera
Dan Li
Cindy Lee
Samuel Haywood
Xiaoping Chen
Qing Chang
Guotai Xu
Hsuan-An Chen
Elisa de Stanchina
Charles Sawyers
Neal Rosen
Andrew C. Hsieh
Yu Chen
Brett S. Carver
author_sort Ninghui Mao
title Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
title_short Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
title_full Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
title_fullStr Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
title_full_unstemmed Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
title_sort defining the therapeutic selective dependencies for distinct subtypes of pi3k pathway-altered prostate cancers
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/907e2e85e15748fa85c06a824495c169
work_keys_str_mv AT ninghuimao definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT zedazhang definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT youngsunlee definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT daniellechoi definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT auraagudelorivera definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT danli definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT cindylee definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT samuelhaywood definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT xiaopingchen definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT qingchang definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT guotaixu definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT hsuananchen definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT elisadestanchina definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT charlessawyers definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT nealrosen definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT andrewchsieh definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT yuchen definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
AT brettscarver definingthetherapeuticselectivedependenciesfordistinctsubtypesofpi3kpathwayalteredprostatecancers
_version_ 1718381566867013632